← FDA ENFORCEMENT
D-0040-2025Class I

Staska Pharmaceuticals, Inc.

Recalling firm
Staska Pharmaceuticals, Inc.
Product type
Drug
Status
Terminated
Report date
2024-11-13
Distribution
Nationwide in the USA
Firm state
NE
Product quantity
4773 vials
Initiated by
Voluntary: Firm initiated
SPEQ quality domain
Environmental Monitoring
Reason for recall

Presence of Particulate Matter: Presence of glass particulates.

Product description

Ascorbic Acid Inj. Solution, 25,000mg/50mL (500mg/mL), 50mL single use vial, Rx only, Staska Pharmaceuticals, 742 Evergreen Drive, Bennet, NE 68317

Code / lot info

Lot #SP2400058, Exp 12/31/2024

Other recalls SPEQ maps to Environmental Monitoring
2026-07-22Class IArgon Medical Devices, Inc2026-07-22Class IIOlympus Corporation of the Americas2026-07-22Class IIChiesi USA, Inc.2026-07-22Class IICareFusion 213, LLC
See all Environmental Monitoring recalls →

Data: U.S. FDA openFDA enforcement API. Recall details are as reported by the FDA. The quality-domain mapping and severity are a SPEQ editorial interpretation of the recall reason, not an official FDA classification.